Streetbeat News

Stock Prices

BDX

CAH

Becton, Dickinson, And Company (BDX) is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health Inc's (CAH) Monoject syringes, as announced by the FDA. The recall is classified as Class I, indicating a risk of serious injury or death. The issue arose after Cardinal Health changed the dimensions of its Monoject syringes during rebranding. There have been 13 reported injuries but no deaths. BDX shares saw a slight decline of 0.15% to $237.89.

Portfolio Pulse from Vandana Singh

December 04, 2023 | 7:22 pm

AR

Truist Securities analyst Bertrand Donnes downgraded Antero Resources Corp (AR) to Hold from Buy, reducing the price target from $37.00 to $28.00. Donnes anticipates depressed investor sentiment and potential reductions in Street estimates/price targets for AR in the coming months. Despite AR's quality inventory, the lack of commodity recovery may limit upside potential. The analyst also lowered EBITDAX estimates for 2023 and 2024, reflecting a reduced NGL/gas differential outlook and predicting higher FCF Y/Y but expecting near-term downward revisions. AR shares dropped by 3.5% to $23.05.

Portfolio Pulse from Lekha Gupta

December 04, 2023 | 7:17 pm

AMZN

Amazon reported record-breaking holiday sales, surpassing last year's performance in the same period. Despite a post-Black Friday 2% stock increase, shares later fell by 1.40%. The stock is at a critical support level of $142, indicating a potential rally point. Amazon's stock has risen 69% this year, with a 9% gain in November, closing at $147.03 on December 1.

Portfolio Pulse from Zaheer Anwari

December 04, 2023 | 7:12 pm

PRO

Pros Holdings (NYSE:PRO) has received positive analyst ratings in the last quarter, with 3 bullish and 1 somewhat bullish ratings out of 4 total. The average 12-month price target for PRO is $41.75, which is a 4.38% increase from the previous target of $40.00. Analysts base their ratings on financial analysis and company performance predictions.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 7:00 pm

MTB

Over the past 3 months, 5 Wall Street analysts have rated M&T Bank (NYSE:MTB) stock as predominantly somewhat bullish with 4 out of 5 giving such ratings and 1 being indifferent. The average price target is $150.13, suggesting an upside from the current price of $134.31. This target is a 5.28% decrease from the previous target of $158.50. Analysts derive their ratings from various sources including company calls, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 7:00 pm

WBTCUSD

Wrapped Bitcoin (WBTC) has seen a significant price increase of 5.29% in the last 24 hours, reaching $41,615.00. Over the past week, WBTC has gained 12.0%, rising from $36,944.56. Despite the recent gains, it is still below its all-time high of $70,643.00. The trading volume for WBTC has increased by 136.0% over the past week, while the circulating supply has slightly decreased by 0.54%. The current market cap for WBTC is $6.67 billion, ranking it 16th in the market.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 7:00 pm

AR

Over the last 3 months, 8 Wall Street analysts have provided ratings for Antero Resources (NYSE:AR), with 5 bullish and 3 indifferent. No bearish ratings were reported. The average price target is $32.38, representing an implied upside from the current price of $22.82. This target has decreased by 2.29% from the previous target of $33.14. Analysts' ratings are based on research and provide guidance to investors, though they reflect opinions and can vary in accuracy.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 7:00 pm

RCM

Over the last 3 months, 6 Wall Street analysts have provided ratings for R1 RCM (NASDAQ:RCM), with an average price target of $19.08, representing an upside from the current price of $10.87. The consensus includes 1 bullish, 4 somewhat bullish, and 1 indifferent rating. The current average price target has decreased by 6.15% from the previous target of $20.33. Analysts typically review stocks quarterly, considering financial statements, meetings, and insider insights.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 7:00 pm

PDD

PDD Holdings (NASDAQ:PDD) has delivered an impressive average annual return of 47.34% over the past 5 years, outperforming the market by 35.75%. An initial investment of $1000 in PDD stock 5 years ago would be worth $6,348.67 today. PDD Holdings currently has a market cap of $187.85 billion.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 7:00 pm

VRTX

Vertex Pharmaceuticals (NYSE:VRTX) has seen a decrease in short interest, with the short percent of float dropping 3.96% since the last report. The company has 2.51 million shares sold short, representing 0.97% of available shares. The average time to cover these short positions is 1.64 days. Short interest is a market sentiment indicator, and a decrease suggests investors may be more bullish on VRTX. Compared to its peers, VRTX has a lower short interest as a percentage of float, with the peer group average at 5.26%.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 7:00 pm